Guozhong Gong

HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study

Peng Hu, Jia Shang, Wenhong Zhang et al. · Journal of Clinical and Translational Hepatology · 2018 · 165 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings

Dao-zhen Xu, Xuanyi Wang, Xinliang Shen et al. · Journal of Hepatology · 2013 · 150 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries

Jin-Lin Hou, Wei Zhao, Changhyeong Lee et al. · Clinical Gastroenterology and Hepatology · 2019 · 112 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C

Yongfang Jiang, Hui Bao, Yan Ge et al. · Gut · 2014 · 87 citations · Full text

Life Sciences, Cell Biology, Pathobiology +17

Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study

Guangdi Li, Yacong Liu, Xixi Jing et al. · Aging · 2020 · 73 citations · Full text

Education, Geriatric Medicine, Infectious Diseases +10